Clinical Trial

Gaze Contingent Attentional Reinforcement in Major Depressive Disorder

Name: Gaze Contingent Attentional Reinforcement in Major Depressive Disorder — clinical trial record (NCT07364981)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The main objective of this randomized controlled trial is to evaluate whether a gaze-contingent feedback task using negative reinforcement can serve as an effective attention-modification procedure and contribute to the treatment of Major Depressive Disorder (MDD).

Trial Details

NCT Number	NCT07364981
Lead Sponsor	Tel Aviv University
Conditions	Major Depressive Disorder (MDD)
Enrollment	60 participants
Start Date	2026-01-01
Primary Completion	2030-01-01 (estimated)
Study Completion	2030-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-01-23